Look around
and comment.
jksw
A
revolutionary drug that melts away cancer in some stage four patients has been
given fast-track approval in the United States.
Key pointsVenetoclax
- Trial of Melbourne-developed drug shows four out of five patients had a positive result, with complete remission for one in five
- Venetoclax has received fast-track approval for use in the United States
- Manufacturer has applied for it to be listed on the Australia's PBS
Melbourne-developed
Venetoclax is one of a new generation of targeted drugs which attack specific
cancer-causing biological factors like cell-structure mutations.
Robert Oblak
was fighting a recurrence of chronic lymphocytic leukaemia, a cancer of the
blood and bone marrow, when he was chosen to take part in a trial in 2013.
"I think
I was the eleventh person in the world to have it," he told 7.30.
"It was
amazing."
Within a year
his leukaemia went into remission.
"It
causes no side-effects. Nothing, absolutely nothing," he said.
No comments:
Post a Comment